HIV/AIDS research
The United States National Institutes of Health stops its trial of an experimental HIV vaccine (HVTN 702) amidst poor results. The trial involved more than 5,000 people in South Africa.
Sources: BBC News
Changes
- The United States National Institutes of Health stops its trial of an experimental vaccine (HVTN 702) that could protect people against HIV. The trial involved more than 5,000 people in South Africa.
- The United States National Institutes of Health stops its trial of an experimental HIV vaccine (HVTN 702) amidst poor results. The trial involved more than 5,000 people in South Africa.